To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
74 Current news of Bayer
rss
Dr. Dirk Ehle appointed Head of Bayer HealthCare's Animal Health Division
04-30-2012
Dr. Dirk Ehle has been appointed Head of the Animal Health Division of Bayer HealthCare AG effective May 1, 2012. The 42-year-old succeeds Dr. Jean-Luc Lowinski, who is leaving the company at his own request. As divisional head, Ehle will also be member of the Bayer HealthCare Executive ...
Encouraging start to the year for Bayer
04-27-2012
The Bayer Group saw a successful start to 2012. “All the subgroups contributed to the encouraging increase in sales, particularly CropScience, which experienced a strong start to the season,” Management Board Chairman Dr. Marijn Dekkers explained on Thursday when the first-quarter interim ...
Bayer sets ambitious targets for 2014
03-16-2012
The Bayer Group sees good perspectives for its businesses in the medium term. “In the life science areas – HealthCare and CropScience – we anticipate further increases in sales and margins through 2014,” said CEO Dr. Marijn Dekkers at the “Meet Management” investor conference on Wednesday in ...
Bayer: sales and EBIT at record levels
03-01-2012
The Bayer Group had a very successful year in 2011 both strategically and operationally, posting record levels of sales and EBIT. “We achieved the Group targets that we raised after the first quarter,” said Bayer CEO Dr. Marijn Dekkers at the Financial News Conference in Leverkusen on ...
Bayer plans further expansion in Asia
Plans to expand production, distribution network and research
11-17-2011
The Bayer Group plans to further expand its production, distribution network and research activities in Asia and considerably increase its sales in the region in the coming years. “We aim to achieve a more than 60 percent increase in our sales in Asia by 2015,” Management Board Chairman Dr. ...
After a good third quarter: Bayer confirms Group outlook
Net income more than doubled to EUR 642 million (plus 125.3 percent)
11-01-2011
The Bayer Group achieved further sales growth and significantly increased earnings in the third quarter of 2011. “It was a good quarter for Bayer,” Management Board Chairman Dr. Marijn Dekkers said Thursday at the presentation of the interim report. He described the continuing growth momentum ...
Bayer remains “best in class” in sustainability
Renewed inclusion in Dow Jones Sustainability Indices
09-13-2011
Bayer remains “best in class” in sustainability. This is demonstrated by the company's renewed inclusion in both the Dow Jones Sustainability World Index (DJSI World) and the Dow Jones Sustainability Europe Index (DJSI Europe). Bayer has been listed continuously in the DJSI World since its ...
Bayer Healthcare to acquire Pathway Medical Technologies
Transaction complements business portfolio in vascular intervention technologies
09-07-2011
Bayer HealthCare announced that its affiliate, MEDRAD, Inc. has acquired Pathway Medical Technologies, Inc., of Kirkland, Wash. Financial terms of the agreement were not disclosed. With this acquisition, Bayer HealthCare is strengthening its MEDRAD Interventional business by expanding its ...
FDA Grants Fast Track Designation to Bayer’s Investigational Compound Alpharadin for the Treatment of Castration Resistant Prostate Cancer in Patients with Bone Metastases
08-24-2011
Bayer HealthCare announced that its investigational compound AlpharadinTM (radium-223 chloride), which is exclusively licensed from Algeta ASA, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of castration-resistant (hormone refractory) ...
Bayer off to a successful start to 2011
First quarter of 2011: all subgroups lift sales and earnings
04-29-2011
The Bayer Group got off to a successful start to 2011. “All three subgroups contributed to the strong start to the year with sales and earnings increases,” Bayer CEO Dr. Marijn Dekkers explained on Thursday when the company’s first-quarter results were released. He was especially pleased at ...
